Results 151 to 160 of about 276,787 (297)

Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine

, 2020
Samuel Kohtala, Okko Alitalo, Marko Rosenholm, Stanislav Rozov, Tomi Rantamäki   +4 more
openalex   +1 more source

The Efficacy of Pharmacological Treatment of Depression in Anorexia Nervosa and Underweight Patients: A Systematic Review

European Eating Disorders Review, EarlyView.
ABSTRACT Objective Major depressive disorder (MDD) is a frequent comorbidity in anorexia nervosa (AN). This review aimed to evaluate evidence on the effectiveness of pharmacological treatments for MDD in underweight individuals. Method A systematic review was conducted using PubMed, Medline, PsycINFO, and Web of Science through March 2025.
M. J. Besjes, S. H. W. Mares, A. A. van Elburg, J. Spijker   +3 more
wiley   +1 more source

Rapid Antidepressant Effects of Deep Brain Stimulation and Their Relation to Surgical Protocol

, 2020
Patricio Riva‐Posse, Andrea Crowell, Kathryn Wright, Allison C. Waters, Kisueng Choi, Steven J. Garlow, Paul E. Holtzheimer, Robert E. Gross, Helen S. Mayberg   +8 more
openalex   +2 more sources

Food Addiction Is Strongly Associated With Psychopathology and Reduced Psychological Well‐Being Among Adults Irrespective of BMI

European Eating Disorders Review, EarlyView.
ABSTRACT Background and Aims Food addiction has been linked to psychopathology and reduced psychological well‐being. Here, we investigated whether these associations are mainly driven by food addiction itself or mediated via an increase in BMI. Methods Data stem from a nationwide survey from Denmark (n = 1474 participants).
Christina Horsager, Emil Færk, Jens Meldgaard Bruun, Marlene B. Lauritsen, Søren Dinesen Østergaard   +4 more
wiley   +1 more source

GDF15 Is Elevated in Eating Disorders and Is Involved in the Gut‐Brain Axis via Ghrelin

European Eating Disorders Review, EarlyView.
ABSTRACT Objective GDF15 induces anorexia and visceral discomfort, regulating appetite, food intake and potentially metabolic responses. However, its role in eating disorders remains unexplored. Method A total of 145 participants were recruited (60 patients with anorexia nervosa, 20 with bulimia nervosa, 13 with binge eating disorder, 52 participants ...
Livio Tarchi, Giulia Brancolini, Sara Giachetti, Gaia Maiolini, Emanuele Cassioli, Eleonora Rossi, Gianluca Villa, Rachele Garella, Roberta Squecco, Paolo Rovero, Paolo Comeglio, Valdo Ricca, Francesco De Logu, Romina Nassini, Giovanni Castellini   +14 more
wiley   +1 more source

INTERACTION OF PERSPECTIVE ANTIDEPRESSANT WITH NOOTROPIC PROPERTIES 2-METHYL-3-PHENYLAMINOMETHYLQUINOLIN-4-ONE WITH CNS STIMULANTS AND DEPRESSANTS

, 2014
И. Н. Подольский, С. Ю. Штрыголь, В. А. Зубков, І. С. Гриценко   +3 more
openalex   +2 more sources

THE RADIOIMMUNOASSAY OF TRICYCLIC ANTIDEPRESSANTS [PDF]

, 1976
G. Wynne Aherne, E. M. Piall, V. Marks
openalex   +1 more source

Efficacy and Safety of Lisdexamfetamine Versus Topiramate Versus Naltrexone/Bupropion in Individuals With Binge Eating Disorder: A Network Meta‐Analysis

European Eating Disorders Review, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of lisdexamfetamine, topiramate, and naltrexone/bupropion for treating binge eating disorder (BED) using network meta‐analysis. Method We systematically searched PubMed, Scopus, ClinicalTrials.gov, and Cochrane Central up to February 2025 for randomized controlled trials evaluating these medications
Tamer Hodrob, Ibrahim Ismail, Alaaeddin Abusalameh, Celina R. Andonie, Omar Ayesh, Hazem Ayesh   +5 more
wiley   +1 more source

PMH31 A GPRD-BASED COMPARISON OF SECOND-LINE ANTIDEPRESSANT THERAPY WITH ESCITALOPRAM AND VENLAFAXINE

, 2008
AG Wade, Dominique Milea, Nicolas Despiégel, Florent Guelfucci, Mondher Toumi   +4 more
openalex   +1 more source

Antidepressant Drug Sertraline against Human Cancer Cells [PDF]

, 2022
Diana Duarte, Nuno Vale
openalex   +1 more source